Sedivention
Devices for therapy and prevention
Invented in Bavaria
Our Partners and Supporters
We work internationally with experts in engineering, regulatory, and clinical.
Medicine is our passion
With a long and intense experience in clinical practise, we know where the medical need is.
With our devices, we aim to address these needs and make therapy less invasive.
Ute Nollert, MD, founder of Sedivention experienced the whole spectrum of anesthesiology from liver transplant and ICU to cardiac surgery and dental interventions. The setting was international from university hospitals to ambulatory care.
The Team
André Burch MSc, EMBA
28+ years in global leading medical device companies
•Board of Directors, VP Finance & Admin at BIOTRONIK Vascular Intervention
•VP Clinical/Regulatory Affairs, VP New Businesses (startup approach)
•Director R&D at BIOTRONIK VI
•Director R&D, Boston Scientific and Pfizer/Schneider Worldwide
•ETH Zurich / IMD Lausanne, Switzerland
Ute Nollert, MD
•Consultant in anaesthesia at the University of Munich, LMU for 13 years
•European Diploma in Anaesthesiology and Intensive Care
•Author o f numerous scientific articles and textbook chapters in particular ambulant anesthesia and conscious sedation
Consultant Sana Klinik, Munich, Germany
Stéphane Delaloye,
PhD, EMBA
25+ years in medical device industry, numerous key patents granted
•COO/VP R&D, Symetis AG – from start to successful exit in 2017
•Director R&D, Biotronik AG
•Manager R&D, Boston Scientific
•Manager R&D, Pfizer/Schneider WW
ETH Zurich / HSG St. Gallen, Switzerland
© Sedivention GmbH All rights reserved
Wir benötigen Ihre Zustimmung zum Laden der Übersetzungen
Wir nutzen einen Drittanbieter-Service, um den Inhalt der Website zu übersetzen, der möglicherweise Daten über Ihre Aktivitäten sammelt. Bitte prüfen Sie die Details und akzeptieren Sie den Dienst, um die Übersetzungen zu sehen.